{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T03:08:33Z","timestamp":1787972913283,"version":"build-2784847793"},"reference-count":20,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.jbspin.2025.105869","type":"journal-article","created":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T03:05:18Z","timestamp":1740452718000},"page":"105869","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Could the anti-modified protein antibody concept help better define seronegative rheumatoid arthritis?"],"prefix":"10.1016","volume":"92","author":[{"given":"Pauline","family":"Brevet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Fr\u00e9ret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Barat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Lequerr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Boyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Vittecoq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2025.105869_bib0105","doi-asserted-by":"crossref","first-page":"e003927","DOI":"10.1136\/rmdopen-2023-003927","article-title":"Utility of testing for third-generation anticyclic citrullinated peptide (anti-CCP3) antibodies in individuals who present with new musculoskeletal symptoms but have a negative second-generation anticyclic citrullinated peptide (anti-CCP2) antibody test","volume":"10","author":"Di Matteo","year":"2024","journal-title":"RMD Open"},{"key":"10.1016\/j.jbspin.2025.105869_bib0110","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s13075-020-02191-2","article-title":"Presence of autoantibodies in \u201cseronegative\u201d rheumatoid arthritis associates with classical risk factors and high disease activity","volume":"22","author":"Reed","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2025.105869_bib0115","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/art.41089","article-title":"Comprehensive profiling of the rheumatoid arthritis antibody repertoire","volume":"72","author":"Lo","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jbspin.2025.105869_bib0120","doi-asserted-by":"crossref","first-page":"627986","DOI":"10.3389\/fimmu.2021.627986","article-title":"A comprehensive evaluation of the relationship between different IgG and IgA anti-modified protein autoantibodies in rheumatoid arthritis","volume":"12","author":"Gr\u00f6nwall","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jbspin.2025.105869_bib0125","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1136\/annrheumdis-2013-205109","article-title":"Anti-CarP antibodies in two large cohorts of patients with rheumatoid arthritis and their relationship to genetic risk factors, cigarette smoking and other autoantibodies","volume":"73","author":"Jiang","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2025.105869_bib0130","doi-asserted-by":"crossref","first-page":"105790","DOI":"10.1016\/j.jbspin.2024.105790","article-title":"2024 update of the recommendations of the French Society of Rheumatology for the diagnosis and management of patients with rheumatoid arthritis","volume":"91","author":"Fautrel","year":"2024","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2025.105869_bib0135","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1136\/annrheumdis-2015-208873","article-title":"Patients with seronegative RA have more inflammatory activity compared with patients with seropositive RA in an inception cohort of DMARD-na\u00efve patients classified according to the 2010 ACR\/EULAR criteria","volume":"76","author":"Nordberg","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2025.105869_bib0140","doi-asserted-by":"crossref","first-page":"e000752","DOI":"10.1136\/rmdopen-2018-000752","article-title":"Comparing the disease course of patients with seronegative and seropositive rheumatoid arthritis fulfilling the 2010 ACR\/EULAR classification criteria in a treat-to-target setting: 2-year data from the ARCTIC trial","volume":"4","author":"Nordberg","year":"2018","journal-title":"RMD Open"},{"key":"10.1016\/j.jbspin.2025.105869_bib0145","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.3899\/jrheum.140082","article-title":"Prognosis of seronegative patients in a large prospective cohort of patients with early inflammatory arthritis","volume":"41","author":"Barra","year":"2014","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2025.105869_bib0150","doi-asserted-by":"crossref","first-page":"152382","DOI":"10.1016\/j.semarthrit.2024.152382","article-title":"Risk of cardiovascular comorbidities before and after the onset of rheumatic diseases","volume":"65","author":"Aaramaa","year":"2024","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2025.105869_bib0155","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/rheumatology\/key263","article-title":"Autoantibody status is not associated with early treatment response to first-line methotrexate in patients with early rheumatoid arthritis","volume":"58","author":"Dekkers","year":"2019","journal-title":"Rheumatology"},{"key":"10.1016\/j.jbspin.2025.105869_bib0160","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1093\/rheumatology\/keaa393","article-title":"The impact of seropositivity on the effectiveness of biologic anti-rheumatic agents: results from a collaboration of 16 registries","volume":"60","author":"Courvoisier","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2025.105869_bib0165","author":"Maldonado","year":"2024"},{"key":"10.1016\/j.jbspin.2025.105869_bib0170","doi-asserted-by":"crossref","first-page":"17372","DOI":"10.1073\/pnas.1114465108","article-title":"Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage","volume":"108","author":"Shi","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jbspin.2025.105869_bib0175","doi-asserted-by":"crossref","first-page":"733511","DOI":"10.3389\/fimmu.2021.733511","article-title":"Anti-carbamylated fibrinogen antibodies might be associated with a specific rheumatoid phenotype and include a subset recognizing in vivo epitopes of its \u03b3 chain one of which is not cross reactive with anti-citrullinated protein antibodies","volume":"12","author":"Brevet","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jbspin.2025.105869_bib0180","doi-asserted-by":"crossref","first-page":"e004746","DOI":"10.1136\/rmdopen-2024-004746","article-title":"Immune reactivity directed against the carbamylated fibrinogen \u03b1 chain does not cross-react with citrullinated fibrinogen immunodominant peptides in patients with rheumatoid arthritis","volume":"10","author":"Brevet","year":"2024","journal-title":"RMD Open"},{"key":"10.1016\/j.jbspin.2025.105869_bib0185","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1002\/art.40237","article-title":"Association of the presence of anti-carbamylated protein antibodies in early arthritis with a poorer clinical and radiologic outcome: data from the French ESPOIR Cohort","volume":"69","author":"Truchetet","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jbspin.2025.105869_bib0190","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1136\/annrheumdis-2019-216709","article-title":"Anti-carbamylated proteins antibody repertoire in rheumatoid arthritis: evidence of a new autoantibody linked to interstitial lung disease","volume":"79","author":"Castellanos-Moreira","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2025.105869_bib0195","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1002\/art.42162","article-title":"A risk score to detect subclinical rheumatoid arthritis-associated interstitial lung disease","volume":"74","author":"Juge","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jbspin.2025.105869_bib0200","series-title":"POS1227 the repertoire of anti-modified protein antibodies and the therapeutic response degree in ACPA+ RA patients treated with methotrexate\/abatacept. Scientific Abstracts, BMJ Publishing Group Ltd and European League Against Rheumatism","author":"Brevet","year":"2024"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X25000284?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X25000284?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T19:26:44Z","timestamp":1758828404000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X25000284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S1297319X25000284"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2025.105869","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Could the anti-modified protein antibody concept help better define seronegative rheumatoid arthritis?","name":"articletitle","label":"Article Title"},{"value":"Joint Bone Spine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbspin.2025.105869","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Soci\ufffdt\ufffd Fran\ufffdaise de Rhumatologie. Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105869"}}